Semaglutide
medicationA GLP-1 medication that reduces appetite, approved for weight management and type 2 diabetes.
Tesofensine is a medication that is research only, not approved for human use in the US.
Also known as NS2330
Tesofensine is not a peptide. It is an investigational medicine that affects several brain neurotransmitters and is promoted online for weight loss despite lacking FDA approval.

Not approved for human use in the US. We list it so you can learn what it is, but we do not link to anyone selling it. Not FDA-approved and not lawfully marketed as a personal weight-loss product in the US.
As of September 28, 2026.
Human weight-loss trials exist, but safety questions and the absence of FDA approval remain important.
These save with the compound when you add it to My Journal, so they’re on the printout for your visit.
Tesofensine is not approved for human use, so DiscoverMedica links to no seller.
We don’t link to sellers of research-only compounds. Products sold “for research use only” are not made for people and are not held to pharmaceutical quality standards.
Educational information only, not medical advice. It does not replace a conversation with a licensed clinician.
A GLP-1 medication that reduces appetite, approved for weight management and type 2 diabetes.
A weekly GIP and GLP-1 medication approved for weight management, sleep apnea and type 2 diabetes.
An older, daily GLP-1 injection for weight management and diabetes, now available as a generic.
A cheap, decades-old diabetes pill that some people ask about for weight and healthy aging.